investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:   Healthcare ↓1.17   Disease: Infectious ↓1.17   Disease: Cardiovascular ↓1.17 «See more»   Biotechnology ↑4.53   Artificial Intelligence ↑4.9   Pharmaceutical  ↑5.35

Biology stock segment: trending tickers

ARDX Ardelyx, Inc. - Common Stock 0.28% down 1.1% -0.82 + Biology, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1437402/000143740226000003/0001437402-26-000003-index.htm
8-K - ARDELYX, INC. (0001437402) (Filer)
+ My List
BLFS BioLife Solutions, Inc. - Common Stock 2.61% down 3.19% -0.58 + Medicine, Biology

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/834365/000162828026001767/0001628280-26-001767-index.htm
8-K - BIOLIFE SOLUTIONS INC (0000834365) (Filer)
+ My List
DVAX Dynavax Technologies Corporation - Common Stock 0.00% 0 + Immunology, Biology, Biopharma, Medicine, Vaccines

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1029142/000119312526043821/0001193125-26-043821-index.htm
8-K - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
+ My List
EQ Equillium, Inc. - Common Stock -1.29% -1.29% 0 + Biology, Medicine

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1746466/000119312525280202/0001193125-25-280202-index.htm
10-Q - Equillium, Inc. (0001746466) (Filer)
+ My List
EVGN Evogene Ltd. - Ordinary Shares 4.9% 4.9% 0 + Medicine, Biology, Artificial Intelligence

Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1574565/000117891326000426/0001178913-26-000426-index.htm
6-K - Evogene Ltd. (0001574565) (Filer)
+ My List
ILMN Illumina, Inc. - Common Stock 1.24% up 1.07% 0.17 + Medicine, Gene and cell, Biology, Cancer fight, Reproductive health

Last highlighted: 10-K Sec report https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/0001110803-26-000024-index.htm
10-K - ILLUMINA, INC. (0001110803) (Filer)
+ My List
LIFE aTyr Pharma, Inc. - Common Stock 1.89% down 2.63% -0.74 + Biology, RNA, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1339970/000119312525202865/0001193125-25-202865-index.htm
8-K - aTYR PHARMA INC (0001339970) (Filer)
+ My List
QTRX Quanterix Corporation - Common Stock -1.17% up -1.84% 0.67 + Healthcare, Biology, Disease: Infectious, Disease: Cardiovascular, Cancer fight, Disease: Oncology

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1503274/000162828026001369/0001628280-26-001369-index.htm
8-K - Quanterix Corp (0001503274) (Filer)
+ My List
STTK Shattuck Labs, Inc. - Common Stock 2.2% down 2.44% -0.24 + Medicine, Biology

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1680367/000119312526039488/0001193125-26-039488-index.htm
8-K - Shattuck Labs, Inc. (0001680367) (Filer)
+ My List
ZNTL Zentalis Pharmaceuticals, Inc. - common stock 5.35% 5.35% 0 + Cancer fight, Biology, Pharmaceutical , Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1725160/000172516026000003/0001725160-26-000003-index.htm
8-K - Zentalis Pharmaceuticals, Inc. (0001725160) (Filer)
+ My List
ABCL AbCellera Biologics Inc. - Common Shares 6.71% down 7.35% -0.64 + Medicine, Biology

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1703057/000170305726000003/0001703057-26-000003-index.htm
8-K - AbCellera Biologics Inc. (0001703057) (Filer)
+ My List
ADAG Adagene Inc. - ADS, each representing 1.25 ordinary shares 10.32% down 12.9% -2.58 + Medicine, Biology
+ My List
EVAX Evaxion Biotech A/S - American Depositary Share 4.53% down 5.14% -0.61 + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology

Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1828253/000117184326000227/0001171843-26-000227-index.htm
6-K - Evaxion A/S (0001828253) (Filer)
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.